Evidence map›Paper›PMID 38750588›Full record

ArticleBiology of sex differences2024

Sex- and species-specific contribution of CD99 to T cell costimulation during multiple sclerosis.

Ingo Winschel, Anne Willing, Jan Broder Engler, Mark Walkenhorst, Nina Meurs, Lars Binkle-Ladisch, Marcel S Woo, Lena Kristina Pfeffer, Jana K Sonner, Uwe Borgmeyer and 5 more

Abstract read
In one paragraph

Article in Biology of sex differences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Single-Cell Profiling Reveals Clonally Expanded CX3CR1Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Ingo WinschelInstitute of Neuroimmunology and Multiple Sclerosis, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.ORCID 0000-0001-9487-7070
Anne WillingInstitute of Neuroimmunology and Multiple Sclerosis, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.ORCID 0000-0002-0924-2829
Jan Broder EnglerInstitute of Neuroimmunology and Multiple Sclerosis, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.ORCID 0000-0002-3169-2076
Mark WalkenhorstInstitute of Neuroimmunology and Multiple Sclerosis, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.ORCID 0000-0002-2277-9532
Nina MeursInstitute of Neuroimmunology and Multiple Sclerosis, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.ORCID 0000-0001-5366-0123
Lars Binkle-LadischInstitute of Neuroimmunology and Multiple Sclerosis, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.ORCID 0000-0001-6168-3210
Marcel S WooInstitute of Neuroimmunology and Multiple Sclerosis, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.ORCID 0000-0002-1306-2708
Lena Kristina PfefferInstitute of Neuroimmunology and Multiple Sclerosis, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.ORCID 0000-0003-3057-6492
Jana K SonnerInstitute of Neuroimmunology and Multiple Sclerosis, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.ORCID 0000-0002-4700-272X
Uwe BorgmeyerCenter of Molecular Neurobiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.ORCID 0000-0003-3727-4083
Sven Hendrik HagenResearch Department Virus Immunology, Leibniz Institute of Virology, Hamburg, Germany.ORCID 0009-0009-6881-8670
Benjamin GrünhagelResearch Department Virus Immunology, Leibniz Institute of Virology, Hamburg, Germany.ORCID 0009-0007-1498-8960
Janna M ClaussenResearch Department Virus Immunology, Leibniz Institute of Virology, Hamburg, Germany.ORCID 0009-0001-6281-5067
Marcus AltfeldResearch Department Virus Immunology, Leibniz Institute of Virology, Hamburg, Germany.ORCID 0000-0001-5972-2997
Manuel A FrieseInstitute of Neuroimmunology and Multiple Sclerosis, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. manuel.friese@zmnh.uni-hamburg.de.ORCID 0000-0001-6380-2420

Funding

Deutsche Forschungsgemeinschaft FOR5068Deutsche Forschungsgemeinschaft Grant No. 429191104Deutsche Forschungsgemeinschaft project 5Forschungs- und Wissenschaftsstiftung Hamburg LFF-FV 45
6 · The paper itself

Abstract

backgroundDifferences in immune responses between women and men are leading to a strong sex bias in the incidence of autoimmune diseases that predominantly affect women, such as multiple sclerosis (MS). MS manifests in more than twice as many women, making sex one of the most important risk factor. However, it is incompletely understood which genes contribute to sex differences in autoimmune incidence. To address that, we conducted a gene expression analysis in female and male human spleen and identified the transmembrane protein CD99 as one of the most significantly differentially expressed genes with marked increase in men. CD99 has been reported to participate in immune cell transmigration and T cell regulation, but sex-specific implications have not been comprehensively investigated.

methodsIn this study, we conducted a gene expression analysis in female and male human spleen using the Genotype-Tissue Expression (GTEx) project dataset to identify differentially expressed genes between women and men. After successful validation on protein level of human immune cell subsets, we assessed hormonal regulation of CD99 as well as its implication on T cell regulation in primary human T cells and Jurkat T cells. In addition, we performed in vivo assays in wildtype mice and in Cd99-deficient mice to further analyze functional consequences of differential CD99 expression.

resultsHere, we found higher CD99 gene expression in male human spleens compared to females and confirmed this expression difference on protein level on the surface of T cells and pDCs. Androgens are likely dispensable as the cause shown by in vitro assays and ex vivo analysis of trans men samples. In cerebrospinal fluid, CD99 was higher on T cells compared to blood. Of note, male MS patients had lower CD99 levels on CD4

conclusionsOur results demonstrate that CD99 is sex-specifically regulated in healthy individuals and MS patients and that it is involved in T cell costimulation in humans but not in mice. CD99 could potentially contribute to MS incidence and susceptibility in a sex-specific manner.

Indexed as

12E7 AntigenMultiple SclerosisSex CharacteristicsT-LymphocytesAdultAnimalsEncephalomyelitis, Autoimmune, ExperimentalFemaleHumansJurkat CellsMaleMiceMice, Inbred C57BLMice, KnockoutSpecies SpecificitySpleen12E7 AntigenCD99 protein, humanCd99 protein, mouseCerebrospinal fluidExperimental autoimmune encephalomyelitisNeuroinflammationPseudoautosomal regionSex dimorphismT cell costimulationTestosteroneTrans menX and Y chromosomeX chromosome inactivation

Identifiers

PMID38750588
PMCPMC11097467

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.